TG Therapeutics, Inc. (TGTX)
29.19
+0.14
(+0.48%)
USD |
NASDAQ |
Feb 18, 16:00
29.19
0.00 (0.00%)
After-Hours: 19:02
TG Therapeutics EPS Diluted (Quarterly) : 2.428 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| MannKind Corp. | 0.0256 |
| Keros Therapeutics, Inc. | -0.1792 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 390.90M |
| Revenue (Quarterly) | 161.71M |
| Total Expenses (Quarterly) | -229.19M |
| Enterprise Value | 4.734B |
| Gross Profit Margin (Quarterly) | 82.59% |
| Earnings Yield | 9.52% |
| Operating Earnings Yield | 2.18% |
| Normalized Earnings Yield | 9.522 |